What about TSH and Anti-Thyroid Antibodies in Patients with Autoimmune Thyroiditis and Celiac Disease Using a Gluten-Free Diet? A Systematic Review.

celiac disease gluten-free diet systematic review thyroid antibodies thyroid hormones

Journal

Nutrients
ISSN: 2072-6643
Titre abrégé: Nutrients
Pays: Switzerland
ID NLM: 101521595

Informations de publication

Date de publication:
18 Apr 2022
Historique:
received: 16 03 2022
revised: 08 04 2022
accepted: 16 04 2022
entrez: 23 4 2022
pubmed: 24 4 2022
medline: 27 4 2022
Statut: epublish

Résumé

The prevalence of celiac disease (CD) in patients with chronic autoimmune thyroiditis (CAIT) is estimated to be between 2 and 7.8%. A gluten-free diet (GFD) in patients with CD is suggested to have a beneficial effect on CAIT. Thus, the present systematic review was undertaken to achieve more robust evidence about the change in thyroid stimulating hormone (TSH) and thyroid-specific antibodies (T-Ab) levels obtained in CD patients following a GFD. A specific search strategy was planned. The last search was performed on March 2022. The following data were mainly searched for in order to be extracted: sample size, mean and/or median with standard deviation (SD), and error (SE), individually, of thyroid hormones and T-Ab at baseline and after GFD, and the duration of the study. The initial search retrieved 297 records and 6 articles met the inclusion criteria. In total, 50 patients with both CD and CAIT and 45 controls were reported. The effects of a GFD on the thyroid hormonal and immunological profile could be extracted only in a part of the studies. Two studies were case reports. A low risk of bias was observed. These findings advise further studies, ideally randomized, in order to better investigate the potential relationship between GFD and thyroid homeostasis. The level of evidence is not still sufficient to recommend GFD to patients with CAIT.

Identifiants

pubmed: 35458242
pii: nu14081681
doi: 10.3390/nu14081681
pmc: PMC9028602
pii:
doi:

Substances chimiques

Autoantibodies 0
Thyrotropin 9002-71-5

Types de publication

Journal Article Review Systematic Review

Langues

eng

Sous-ensembles de citation

IM

Références

Endocrinol Metab (Seoul). 2021 Apr;36(2):466-467
pubmed: 33934590
Nat Rev Immunol. 2021 Nov;21(11):739-751
pubmed: 33846604
J Plast Reconstr Aesthet Surg. 2019 Aug;72(8):1418-1433
pubmed: 31122827
J Clin Med. 2021 Jul 22;10(15):
pubmed: 34362024
Endocr Pract. 2008 Apr;14(3):381-8
pubmed: 18463048
Thyroid. 2008 Nov;18(11):1171-8
pubmed: 19014325
Front Immunol. 2021 Apr 22;12:673708
pubmed: 33968085
Horm Res. 1999;51(3):124-7
pubmed: 10461017
Clin Rev Allergy Immunol. 2012 Feb;42(1):71-8
pubmed: 22109896
Nutr Rev. 2022 Feb 10;80(3):525-543
pubmed: 34338776
JAMA. 2000 Apr 19;283(15):2008-12
pubmed: 10789670
Nutrients. 2018 Nov 18;10(11):
pubmed: 30453686
J Gastroenterol Hepatol. 2017 Mar;32 Suppl 1:78-81
pubmed: 28244676
PLoS One. 2012;7(3):e33315
pubmed: 22428018
J Autoimmun. 2022 Feb;127:102795
pubmed: 35101708
Scand J Gastroenterol. 2012 Jan;47(1):43-8
pubmed: 22126672
J Clin Gastroenterol. 2002 Sep;35(3):245-8
pubmed: 12192201
Eur J Immunol. 2014 Oct;44(10):3056-67
pubmed: 25043259
Curr Treat Options Neurol. 2018 Mar 17;20(4):8
pubmed: 29549521
Nutrients. 2021 Aug 21;13(8):
pubmed: 34445038
Autoimmun Rev. 2016 Dec;15(12):1125-1128
pubmed: 27639841
Am J Med. 2010 Feb;123(2):183.e1-9
pubmed: 20103030
J Clin Endocrinol Metab. 2012 Mar;97(3):E419-22
pubmed: 22238404
J Endocrinol Invest. 2018 Jan;41(1):91-98
pubmed: 28819917
Genome Med. 2016 Apr 21;8(1):45
pubmed: 27102333
Exp Clin Endocrinol Diabetes. 2019 Jul;127(7):417-422
pubmed: 30060266
Front Immunol. 2017 May 23;8:598
pubmed: 28588585
J Clin Endocrinol Metab. 2020 Jul 1;105(7):
pubmed: 32433771
Am J Gastroenterol. 2001 Mar;96(3):751-7
pubmed: 11280546
PLoS One. 2016 Dec 28;11(12):e0168708
pubmed: 28030626
Ann Ist Super Sanita. 2010;46(4):389-99
pubmed: 21169670
Clin Case Rep. 2021 May 28;9(5):e04170
pubmed: 34094556

Auteurs

Sabrina Malandrini (S)

Department of Internal Medicine, Regional Hospital of Locarno, 6600 Locarno, Switzerland.

Pierpaolo Trimboli (P)

Clinic for Endocrinology, Ente Ospedaliero Cantonale (EOC), 6500 Bellinzona, Switzerland.
Faculty of Biomedical Sciences, Università della Svizzera Italiana (USI), 6900 Lugano, Switzerland.

Gabriele Guzzaloni (G)

Clinic for Endocrinology, Ente Ospedaliero Cantonale (EOC), 6500 Bellinzona, Switzerland.

Camilla Virili (C)

Department of Medico-Surgical Sciences and Biotechnologies, Sapienza University of Rome, 04100 Latina, Italy.

Barbara Lucchini (B)

Clinic for Endocrinology, Ente Ospedaliero Cantonale (EOC), 6500 Bellinzona, Switzerland.
Faculty of Biomedical Sciences, Università della Svizzera Italiana (USI), 6900 Lugano, Switzerland.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH